Update on active surveillance for clinical T1 renal tumors

Gregory A. Joice, Phillip M. Pierorazio, Mohamad E. Allaf

Research output: Contribution to journalReview articlepeer-review


Purpose of review The purpose is to discuss current data on the utilization and outcomes of active surveillance for T1a renal masses. Specifically, to address which patients are optimal for active surveillance and how their outcomes differ from those undergoing immediate treatment. Recent findings Although nephron sparing surgery is the standard of care for small renal masses (SRMs), active surveillance is becoming a more popular intervention given the results of prospective studies revealing active surveillance to be safe and have excellent cancer-specific survival with intermediate follow-up. Older and sicker patients have competing risk of death from other causes when diagnosed with a SRM. Summary Active surveillance is becoming a more popular treatment modality for SRMs given the increasing number of incidental diagnoses and better understanding of their often indolent course. Active surveillance with delayed intervention is a well-tolerated treatment modality and appears to have the most benefit for those patients that are older with more comorbidities.

Original languageEnglish (US)
Pages (from-to)405-409
Number of pages5
JournalCurrent opinion in urology
Issue number5
StatePublished - Sep 1 2016


  • Active surveillance
  • percutaneous renal biopsy
  • renal cell carcinoma
  • small renal mass

ASJC Scopus subject areas

  • Urology


Dive into the research topics of 'Update on active surveillance for clinical T1 renal tumors'. Together they form a unique fingerprint.

Cite this